The Phoenix Mills Limited (PHOENIXLTD) Revenue 2023–2026

Name: The Phoenix Mills Limited (PHOENIXLTD) revenue history 2023-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-20

The Phoenix Mills Limited annual revenue for fiscal 2026 was ₹43.2 billion, an increase of 16.0% from ₹37.2 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

PHOENIXLTD Annual Revenue

Revenue (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹43.2B	₹37.2B	₹39.0B	₹26.0B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PHOENIXLTD Quarterly Revenue

Revenue (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹10.7B	₹12.3B	₹11.2B	₹9.5B	₹10.2B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

3003 Revenue — Hulic Co., Ltd.
1878 Revenue — Daito Trust Construction Co.,Ltd.
3289 Revenue — Tokyu Fudosan Holdings Corporation
3288 Revenue — Open House Group Co., Ltd.
PRESTIGE Revenue — Prestige Estates Projects Limited
CPN Revenue — Central Pattana Public Company Limited

More PHOENIXLTD metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow

All PHOENIXLTD financial statements → Interactive PHOENIXLTD charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.